Department of Cardiology and Cardiovascular Surgery, Department of Histology and Embryology, Samara State Medical University, Samara 443099, Russia.
Biomed Res Int. 2022 Mar 30;2022:6454467. doi: 10.1155/2022/6454467. eCollection 2022.
The study of the metabolism of endogenous molecules is not only of great fundamental significance but also of high practical importance, since many molecules serve as drug targets and/or biomarkers for laboratory diagnostics of diseases. Thus, cardiac troponin molecules have long been used as the main biomarkers for confirmation of diagnosis of myocardial infarction, and with the introduction of high-sensitivity test methods, many of our ideas about metabolism of these cardiac markers have changed significantly. In clinical practice, there are opening new promising diagnostic capabilities of cardiac troponins, the understanding and justification of which are closely connected with the fundamental principles of the metabolism of these molecules. Our current knowledge about the metabolism of cardiac troponins is insufficient and extremely disconnected from various literary sources. Thus, many researchers do not sufficiently understand the potential importance of cardiac troponin metabolism in the laboratory diagnosis of myocardial infarction. The purpose of this comprehensive review is to systematize information about the metabolism of cardiac troponins and during the discussion to focus on the potential impact of cTns metabolism on the laboratory diagnosis of myocardial infarction. The format of this comprehensive review includes a sequential consideration and analysis of the stages of the metabolic pathway, starting from possible release mechanisms and ending with elimination mechanisms. This will allow doctors and researchers to understand the significant importance of cTns metabolism and its impact on the laboratory diagnosis of myocardial infarction.
研究内源性分子的代谢不仅具有重要的基础意义,而且具有很高的实际意义,因为许多分子可作为药物靶点和/或疾病实验室诊断的生物标志物。因此,肌钙蛋白分子长期以来一直被用作心肌梗死诊断的主要生物标志物,并且随着高灵敏度检测方法的引入,我们对这些心脏标志物代谢的许多观念发生了重大变化。在临床实践中,心脏标志物具有新的有前途的诊断能力,对其的理解和证明与这些分子代谢的基本原则密切相关。我们目前对肌钙蛋白代谢的了解不足,且与各种文献来源严重脱节。因此,许多研究人员并没有充分认识到肌钙蛋白代谢在心肌梗死实验室诊断中的潜在重要性。本综述的目的是系统地整理关于肌钙蛋白代谢的信息,并在讨论中重点关注 cTns 代谢对心肌梗死实验室诊断的潜在影响。本综述的格式包括按顺序考虑和分析代谢途径的各个阶段,从可能的释放机制开始,到消除机制结束。这将使医生和研究人员了解 cTns 代谢的重要性及其对心肌梗死实验室诊断的影响。